Becton, Dickinson and Company (NYSE:BDX) Stock Rating Lowered by Bank of America
Becton, Dickinson and Company (NYSE:BDX – Get Free Report) was downgraded by research analysts at Bank of America from a “buy” rating to a “neutral” rating in a research note issued on Thursday, MarketBeat reports. They currently have a $190.00 price objective on the medical instruments supplier’s stock. Bank of America‘s price objective indicates a […]
Becton, Dickinson and Company (NYSE:BDX – Get Free Report) was downgraded by research analysts at Bank of America from a “buy” rating to a “neutral” rating in a research note issued on Thursday, MarketBeat reports. They currently have a $190.00 price objective on the medical instruments supplier’s stock. Bank of America‘s price objective indicates a […]
-ltd-logo-1200x675.png?v=20241211120412&w=240&h=240&zc=2){kind=logo}
